kanamycin a has been researched along with rifampin in 282 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 127 (45.04) | 18.7374 |
| 1990's | 18 (6.38) | 18.2507 |
| 2000's | 28 (9.93) | 29.6817 |
| 2010's | 87 (30.85) | 24.3611 |
| 2020's | 22 (7.80) | 2.80 |
| Authors | Studies |
|---|---|
| Kitaura, K; Mineura, K; Murayama, Y; Nakamizo, A; Nakamizo, Y; Niino, H; Okachi, R; Ono, T | 1 |
| Johansson, CB; Topcu, G; Ulubelen, A | 1 |
| Branland, P; Granet, R; Kaldapa, C; Krausz, P; Sol, V; Verneuil, B | 1 |
| Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
| Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
| Beifuss, U; Conrad, J; Klaiber, I; Leutbecher, H; Mika, S; Möller, W; Mongkolvisut, W; Rösner, H; Sutthivaiyakit, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Dettrakul, S; Kittakoop, P; Rajviroongit, S; Surerum, S | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Govender, K; Govender, P; Govender, T; Kruger, HG; Maguire, GE; Muthusamy, K; Onajole, OK; Pillay, M; van Helden, PD; Wiid, I | 1 |
| Abe, C; Chiba, T; Horita, Y; Inagaki, E; Kuroishi, R; Kurono, Y; Maeda, Y; Mori, M; Nishimura, K; Onozaki, K; Takii, T; Yamamoto, Y | 1 |
| Amsler, CD; Amsler, MO; Baker, BJ; Kyle, DE; Ma, WS; Maiese, WM; McClintock, JB; Mutka, T; Perman, JA; Singh, MP; Vesley, B; Zaworotko, MJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Changtam, C; Hongmanee, P; Suksamrarn, A | 1 |
| Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Floyd, JL; Floyd, JT; Kumar, SH; Smith, KP; Varela, MF | 1 |
| Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chibale, K; Franzblau, SG; Gut, J; Little, S; Rosenthal, PJ; Tukulula, M; Wan, B | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cho, SH; Franzblau, SG; Fryling, NA; Hwang, CH; Jaki, BU; Klein, LL; Lankin, DC; McAlpine, JB; Napolitano, JG; Pauli, GF; Stamets, PE; Wang, Y | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Chibale, K; Kigondu, EM; Warner, DF; Wasuna, A | 1 |
| Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
| Robertson, GT; Silvers, MA; Taylor, CM; Waldrop, GL | 1 |
| Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
| Chaudhary, AS; Cui, J; Damera, K; Hsieh, YH; Jin, J; Tai, PC; Wang, B; Yang, H; Zhang, H | 1 |
| Barry, CE; Boshoff, HI; Candice, Sde M; Chibale, K; Feng, TS; Gessner, RK; Gordon, R; Harris, CJ; Lawrence, N; Moosa, A; Morgans, GL; Naran, K; Soares de Melo, C; Street, LJ; van der Westhuyzen, R; Warner, DF | 1 |
| Liao, S; Rao, X; Shang, S; Shen, M; Si, H; Song, J; Song, Z | 1 |
| Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A | 1 |
| Arkile, MA; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
| Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Khan, FA; Nawale, L; Sangshetti, JN; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
| Abdeen, S; Ambrose, AJ; Anderson, GG; Chapman, E; Frankson, R; Horwich, AL; Johnson, SM; Mammadova, N; Salim, N; Schultz, PG; Summers, CM | 1 |
| Blair, PM; Mitchell, DA; Molloy, EM; Tietz, JI | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chegaev, K; Chung, MC; de Souza, PC; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Lazzarato, L; Marino, LB; Pavan, FR | 1 |
| Kalam Khan, FA; Khedkar, VM; Nawale, L; Sangshetti, JN; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD | 1 |
| Bhalerao, MB; Deshmukh, AR; Dhumal, ST; Khedkar, V; Mane, RA; Nawale, LU; Sarkar, D | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Khedkar, VM; Nawale, L; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Abay, E; Axtman, M; Ballell, L; Barry, CE; Boesche, M; Boshoff, HIM; Brunschwig, C; Chibale, K; Drewes, G; Gessner, RK; Ghidelli-Disse, S; Ghorpade, SR; Gordon, R; Harris, CJ; Lafuente-Monasterio, MJ; Lawrence, N; Lelièvre, J; Mizrahi, V; Moosa, A; Mueller, R; Nchinda, A; Njoroge, M; Pflaumer, H; Rebollo-Lopez, MJ; Santos, G; Sanz, O; Seldon, R; Selenski, C; Simelane, SB; Sirgel, FA; Soares de Melo, C; Street, LJ; Taylor, D; Urones, B; van Helden, P; Warner, DF; Wilson, CR | 1 |
| Bhosle, GS; Fernandes, M; Nawale, L; Sarkar, D; Yeware, AM | 1 |
| Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
| Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Bera, S; Mondal, D | 1 |
| Bekker, OB; Charushin, VN; Danilenko, VN; Ignatenko, NK; Ishmetova, RI; Korotina, AV; Maslov, DA; Rusinov, GL; Shur, KV; Tolshchina, SG; Vatlin, AA | 1 |
| Mabhula, A; Singh, V | 1 |
| Copley, GC; Elshahawi, SI; Hatcher, BE; Hower, JC; Kharel, MK; Liu, Y; Ponomareva, LV; Shaaban, KA; She, QB; Thorson, JS; Van Lanen, SG; Voss, SR; Wang, X; Ye, Q | 1 |
| Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Canaan, S; Cavalier, JF; Magrioti, V; Mallick, I; Mavrikaki, V; Pagonis, A; Poncin, I | 1 |
| Ba, Z; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Yang, Y; Zhang, F; Zhang, J; Zhang, T; Zhang, Y | 1 |
| Chen, S; Ding, CZ; Franzblau, SG; Guo, F; Huang, Z; Li, L; Li, Y; Luo, W; Shen, L; Tang, D; Wang, B; Xu, D; Yang, M; Zhu, Y | 1 |
| Andersen, FD; B Svenningsen, E; Braad Lund, M; Chopin, P; Gotfredsen, CH; Mygind, T; Pedersen, KD; Poulsen, TB; Schramm, A; Tørring, T; Wilkens Juhl, D | 1 |
| Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y | 1 |
| Angeles-Solano, M; Brock, JW; Grosser, MR; Murphy, KE; Pugh, BA; Rao, AB; Wolfe, AL | 1 |
| Alshabani, LA; Bhakta, S; Estrada, DF; Kumar, A; Simons, C; Srithiran, G; Willcocks, SJ | 1 |
| Bates, JH | 1 |
| Newton, RW | 1 |
| Schröder, KH | 1 |
| Tsuji, K | 1 |
| Davidson, PT; Kanes, W; McClatchy, JK; Moulding, TS | 1 |
| Hadgu, AG; Keterew, W; Pattyn, SR; Van Den Breen, L | 1 |
| Tsukamura, M | 6 |
| Iwainsky, H; Reutgen, H; Sesser, I | 1 |
| Kozlova, NV; Kozulitsyna, TI | 1 |
| Hejzlar, M; Trojanová, M; Výmola, F | 1 |
| Ashmarin, IP; Avenirova, EL; Lapina, IK; Movchan, NA | 1 |
| Farrar, WE; Saad, AF | 1 |
| Chormonova, NT | 1 |
| Alberghina, M; Palermo, F | 1 |
| Fowst, G; Nessi, R | 1 |
| Angeretti, A; Gaffodio, AM; Martinetto, P; Montero Quintero, N | 1 |
| Ariji, F; Konno, K; Motomiya, M; Oizumi, K | 1 |
| Spaepen, J; Vandepitte, J; Verbist, L | 1 |
| Videau, D | 1 |
| Ehret, J; Eickhoff, TC; Iannini, PB | 1 |
| Emerson, BB; Harding, AL; Smith, AL; Smith, DH | 1 |
| Oizumi, K | 1 |
| Rosaschino, F | 1 |
| Dall, G; Jenkin, DJ | 1 |
| Grassi, C; Grassi, GG | 1 |
| Cole, ST; Heym, B | 1 |
| Gelber, RH | 2 |
| Holdiness, MR | 2 |
| Heifets, L | 1 |
| Heap, BJ | 1 |
| Franzblau, SG; Nakamura, M; Takeda, T | 1 |
| Lin, TY; McCracken, GH; Olsen, K; Sato, K; Weintrub, L | 1 |
| Frolov, AF; Lukach, IG; Parkhomenko, LV | 1 |
| Altmann, G; Bogokovsky, B | 1 |
| Flemming, J; Virchow, C | 1 |
| Kondo, M; Oishi, T; Tsuchiya, K | 1 |
| Oizumi, K; Oka, S | 1 |
| Canetti, G; Gay, P; Le Lirzin, M | 1 |
| Almeyda, J; Levantine, A | 1 |
| Mühlberger, F | 1 |
| Wolinsky, E | 2 |
| Jentgens, H | 1 |
| Byrd, RB; Gracey, DR; Kaplan, PD | 1 |
| Lynn, R; Phillips, I; Ridley, M; Rimmer, D | 1 |
| Berg, G; Kazemi, H; Stottmeier, K; Zack, MB | 1 |
| Waddell, AD; Walsh, WT; Wisseman, CL | 1 |
| Kotliarov, LM; Pavlov, EP; Tushov, EG | 1 |
| Brunel, A; Cluzel, M; Cluzel, R; Michel, J | 1 |
| Harford, N; Sueoka, N | 1 |
| Naegeli, HR | 1 |
| Clark, J; Wallace, A | 1 |
| Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
| Zierski, M | 1 |
| Baudens, JG; Chabbert, YA | 1 |
| Lucchesi, M; Mancini, P; Matzeu, M | 1 |
| Finland, M; Lee, YH; Toala, P; Wilcox, C | 1 |
| Endo, K | 1 |
| Suzuki, T | 1 |
| Makarevich, NM; Rudoĭ, NM | 1 |
| Kosakai, N; Oguri, T | 1 |
| Eulenberger, J; Mordasini, ER | 2 |
| Lester, W | 1 |
| Plotkina, NS; Vasina, TA; Ved'mina, EA | 1 |
| Bethge, H | 1 |
| Eagle, MC; Goldstein, E; LaCasse, ML | 1 |
| Lang, GR; Levin, S | 1 |
| Kislak, JW | 1 |
| Burgher, LW; Kass, I | 1 |
| Cross, A; Edwards, LD; Landau, W; Levin, S | 1 |
| Koĭfman, SG; Man'kovetskiĭ, EF; Sirota, DS; Vatsyk, MZ | 1 |
| Fillastre, JP | 1 |
| Bass, TM | 1 |
| Blinov, NO; Khokhlov, AS | 1 |
| Daynes, G | 1 |
| Gombosuren, T; Jezek, Z; Mingir, G; Rusinko, M | 1 |
| Elizan, TS; Schwartz, J | 1 |
| Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
| Jeljaszewicz, J; Pulverer, G | 1 |
| George, RH | 1 |
| Nakajo, M; Ogawa, H; Osada, Y | 1 |
| Nakajo, M; Ogawa, H; Osada, Y; Oshima, Y; Une, T | 1 |
| Ogawa, H; Osada, Y; Une, T | 1 |
| Knothe, H; Krcméry, V; Sietzen, W | 1 |
| Anderson, JD; Gillespie, WA; Richmond, MH | 1 |
| Anderson, JD; Ingram, LC; Richmond, MH; Wiedemann, B | 1 |
| Anderson, JD | 1 |
| Oda, K; Ogata, Y; Saito, T; Sugawara, K; Watanabe, T | 1 |
| Ehrlich, RM; Lattimer, JK | 1 |
| Inaba, M; Nakajo, M; Ogawa, H; Osada, Y; Une, T | 1 |
| Borst, J; Knothe, H; Krcméry, V; Sietzen, W | 1 |
| Coudert, J; Lu, HT | 1 |
| Bell, DR | 1 |
| Ellorhaoui, M; Storch, W; Tauchnitz, C | 1 |
| Posada, HR; Sanchez, AS | 1 |
| Bogdanova, LF; Sobolev, VR; Solov'eva, VE; Vlasova, IV | 1 |
| Eule, H | 1 |
| Finegold, SM; Sugihara, PT; Sutter, VL | 1 |
| Koelman, A; Mouton, RP | 1 |
| Courtieu, AL; Guillermet, FN | 1 |
| Azuma, Y; Baba, H; Takahashi, R | 1 |
| Ariji, F; Kumano, N; Madokoro, K; Oka, S; Yamaguchi, J | 1 |
| Benhassine, M; Rahal, K | 1 |
| Drabkina, RO; Ginzburg, TS | 1 |
| Sim, SK | 1 |
| Alvarez, R; Estrada, A; Farga, V; Gay, O; Hiriart, M; Orrego, H; Santiviago, C; Sepúlveda, R; Zimmermann, I; Zúñiga, E | 1 |
| Bals, MG; Filipescŭ, S | 1 |
| Finegold, SM; Sutter, VL | 1 |
| Felgenhauer, F; Lagler, F | 1 |
| Hohenegger, M; Hromadka, A | 1 |
| Raab, WP | 1 |
| Shanson, DC | 1 |
| Drazdáková, M; Hajková, L; Hejzlar, H; Janatová, E; Kittnar, E; Kvicera, J; Nedvídková, J; Pellar, T; Podaná, B; Povolná, A; Sedmidubský, V; Stastná, L | 1 |
| Kuze, F | 1 |
| Amelio, M; Bardessono, F; Giorgis, GE; Moschini, MT | 1 |
| Xiao, XL | 1 |
| Dambrosi, A; Dambrosi, VM; Gonzalez Montaner, LJ; Manassero, M | 1 |
| Dabbs, ER; Looman, K | 1 |
| DeYoung, DR; Roberts, GD; Zimmer, BL | 1 |
| Agostini, H; Fuchs, P; Minton, KW | 1 |
| Hasegawa, N; Kanazawa, M; Kawashiro, T; Sakamaki, F; Terashima, T | 1 |
| Gubkina, MF | 1 |
| Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 1 |
| Tanaka, E | 1 |
| Amitani, R; Hitomi, S; Kuze, F; Matsumoto, H; Mizuno, H; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Yanagihara, K | 1 |
| Chaisuksuwan, R; Pransujarit, V; Punnotok, J; Riantawan, P | 1 |
| Okazawa, Y; Sato, N; Tanno, K; Yamazaki, T | 1 |
| Miyao, H; Okazawa, Y; Sato, N; Tanno, K; Yamashita, K; Yamazaki, T | 1 |
| Amitani, R; Kimoto, T; Kuze, F; Matsumoto, H; Murayama, T; Niimi, A; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Watanabe, I | 1 |
| Naumov, VN; Shaĭkhaev, AIa | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
| Dorozhkova, IR; Medvedeva, IM; Popov, SA | 1 |
| Ghebremichael, S; Hoffner, SE; Koivula, T; Krüüner, A; Mikelsaar, M; Pehme, L | 1 |
| Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
| Bittner, A; Lerner, D; Liu, X; Miller, N; Morrow, BJ; Shaw, KJ; Wan, J | 1 |
| Novozhylova, IO | 1 |
| Kondakova, MN; Pavlova, MV; Sapozhnikova, NV; Skvortsova, LA | 1 |
| Krasnov, VA; Ursov, IG | 1 |
| Belianin, II; Shmelev, EI | 2 |
| Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM | 1 |
| Hamada, M; Ishimatsu, A; Iwata, Y; Kajiki, A; Kitahara, Y; Komori, M; Matsunaga, K; Nagata, N; Wakamatsu, K | 1 |
| Ahn, HJ; Forney, LJ; La, HJ | 1 |
| Kurashima, A; Mikami, J; Mita, M; Nishimura, T; Ohtawa, S; Saito, M; Suzuki, A | 1 |
| Chadha, S; Chandrasekar, V; Chauhan, LS; Dave, PV; Dewan, P; Nalini, S; Narayanan, PR; Paramasivan, CN; Parmar, M; Ramachandran, R; Sahu, S; Sanghvi, AS; Wares, F | 1 |
| Almeida, P; Fissette, K; Martin, A; Paasch, F; Palomino, JC; Portaels, F; Varaine, F; Von Groll, A | 1 |
| Anantharaman, A; Rizvi, MS; Sahal, D | 1 |
| Atkins, JL; Cusumano, Z; Gokel, GW; Patel, MB | 1 |
| Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Zhang, T | 1 |
| Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
| Connolly, C; Friedland, G; Gandhi, N; Moodley, P; Shah, NS; Sturm, AW; Tayob, N; Zetola, N | 1 |
| Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M | 1 |
| de Rijk, P; Fissette, K; Martin, A; Palomino, JC; Ramos, E | 1 |
| Eisenberg, N; Govender, K; Hartman, TE; Hatfull, GF; Jacobs, WR; Jain, P; Kriakov, J; Larsen, MH; Makume, M; Moodley, P; O'Donnell, MR; Sturm, AW; Thaler, DS | 1 |
| Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
| Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B | 1 |
| Lu, J; Pang, Y; Song, Y; Wang, S; Wang, Y; Zhao, Y | 1 |
| Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
| Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
| Casadesús, J; Sánchez-Romero, MA | 1 |
| Chen, Y; Li, GL; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Wu, XC; Xia, Q; Zhao, LL; Zhao, XQ | 1 |
| Huang, ZK; Li, JM; Li, WT; Luo, Q; Xiong, GL; Xu, XM | 1 |
| Choi, SB; Jo, KW; Jung, H; Kang, MR; Lee, YS; Shim, TS | 1 |
| Ardizzoni, E; Aspindzelashvili, R; Bastard, M; de Jong, BC; Goginashvili, L; Kotrikadze, T; Mulders, W; Pangtey, H; Rigouts, L; Varaine, F | 1 |
| Baek, KH; Patra, JK | 1 |
| Sibbald, B | 1 |
| Allnutt, JC; Bacon, J; Bottley, G; Doris, KS; Hatch, KA; Hendon-Dunn, CL; Marriott, AA; Marsh, PD; Taylor, SC; Thomas, SR; Watson, RJ | 1 |
| Deng, YT; Huang, ZK; Li, JM; Luo, Q; Qing, C; Xiong, GL | 1 |
| Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
| Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Rodrigues, C; Rodwell, TC; Seifert, M; Valafar, F; Victor, TC | 1 |
| Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y | 1 |
| Cusumano, Z; Garrad, EC; Gokel, GW; Gokel, MR; Meisel, JW; Negin, S; Patel, MB; Stavri, A | 1 |
| Dixit, P; Jain, A; Jaiswal, I; Singh, M; Singh, P; Singhal, P | 1 |
| Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Jackson, RL; Lin, SY; Rodrigues, C; Rodwell, TC; Seifert, M; Victor, TC | 1 |
| Aldaba, JG; Ama, CG; Geraldino, XD; Lopez, AL; Salonga, AM; Sarol, JN; Sylim, PG | 1 |
| Gnat, S; Nowakiewicz, A; Trościańczyk, A; Zięba, P; Ziółkowska, G | 1 |
| Aono, A; Chikamatsu, K; Igarashi, Y; Mitarai, S; Takaki, A; Yamada, H; Yi, L | 1 |
| Andres, S; Beckert, P; Heyckendorf, J; Hillemann, D; Kohl, TA; Köser, CU; Lange, C; Merker, M; Moradigaravand, D; Niemann, S; Olaru, ID; Parkhill, J; Peacock, SJ; Schleusener, V; Schön, T; Sturegård, E | 1 |
| Antiabong, JF; Lekalakala, RM; Malinga, LA; Maningi, NE; Mbelle, NM | 1 |
| Das, SC; Denman, JA; Doyle, CS; Momin, MAM; Sinha, S; Tucker, IG | 1 |
| Das, SC; Denman, JA; Doyle, CS; Momin, MAM; Tucker, IG | 1 |
| Govindaswamy, A; Jeyaseelan, L; Michael, JS; Pai, R; Sakthi, D | 1 |
| Amukoye, E; Nonoh, J; Nyamache, AK; Ogari, CO | 1 |
| Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M | 1 |
| Das, SC; Momin, MAM; Tucker, IG | 1 |
| Chaiprasert, A; Chongsuvivatwong, V; Faksri, K; Kaewprasert, O; Kusumawati, RL; Pratama, WA; Regmi, SM; Rukmana, A; Sudarmono, P; Tania, T | 1 |
| Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
| de Jong, BC; Decroo, T; Demeulenaere, T; Gumusboga, M; Hossain, MA; Maug, AKJ; Ortuño-Gutiérrez, N; Uwizeye, C; Van Deun, A | 1 |
| Achar, J; Azamat, I; Bayram, H; Gil, H; Gomez, D; Margaryan, H; Nazirov, P; Parpieva, N; Singh, J; Zayniddin, S; Ziba, B | 1 |
| Ji, Y; Li, Z; Liu, Q; Martinez, L; Qiu, B; Song, H; Wang, J; Yang, D | 1 |
| Barr, DA; Davies, G; Koch, A; Lalloo, DG; Mason, M; Meintjes, G; Mizrahi, V; Omollo, C; Warner, DF; Wilkinson, RJ | 1 |
| Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L | 1 |
| Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
| Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F | 1 |
| Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN | 1 |
| Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR | 1 |
| Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
21 review(s) available for kanamycin a and rifampin
| Article | Year |
|---|---|
Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Discovery; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-resistance in
Topics: | 2019 |
Triculamin: An Unusual Lasso Peptide with Potent Antimycobacterial Activity.
Topics: Biological Products; Multigene Family; Peptides; Protein Processing, Post-Translational | 2022 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence.
Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Lincomycin; Mycoses; Nalidixic Acid; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Staphylococcal Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim; Urinary Tract Infections; Vancomycin | 1979 |
[Antistaphylococcal activity of gentamicin].
Topics: Cephalosporins; Cross Infection; Drug Resistance, Microbial; Framycetin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Neomycin; Paromomycin; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Virginiamycin | 1975 |
Chromatographic analysis of antituberculosis drugs in biological samples.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chromatography; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Kinetics; Monitoring, Physiologic; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Viomycin | 1985 |
Contact dermatitis to antituberculosis drugs.
Topics: Aminosalicylic Acid; Antitubercular Agents; Cross Reactions; Dermatitis, Contact; Desensitization, Immunologic; Ethambutol; Humans; Isoniazid; Kanamycin; Rifampin; Skin Tests; Streptomycin | 1986 |
[Chemotherapy].
Topics: Anti-Bacterial Agents; Asparaginase; Bleomycin; Cephalosporins; Cytarabine; Daunorubicin; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Kanamycin; Penicillins; Rifampin; Vincristine | 1972 |
Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Eruptions; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Pyrazinamide; Rifampin; Skin; Stomatitis; Streptomycin; Thioacetazone; Viomycin | 1972 |
[Antitubercular agents].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Kanamycin; Neomycin; Oxytetracycline; Peptides; Rifampin; Streptomycin; Tuberculosis; Viomycin | 1971 |
Diagnosis and treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chloramphenicol; Culture Media; Cycloserine; Cystitis; Erythromycin; Escherichia coli Infections; Gentamicins; Hemagglutination Tests; Humans; Kanamycin; Methenamine; Methods; Nalidixic Acid; Nitrofurantoin; Penicillins; Polymyxins; Pseudomonas Infections; Pyelonephritis; Rifampin; Streptomycin; Sulfonamides; Tetracycline; Trimethoprim; Urinary Tract Infections | 1971 |
[Absorption spectra in UV light of antibacterial antibiotics from Actinomycetes].
Topics: Actinomyces; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Chlortetracycline; Daunorubicin; Gentamicins; Kanamycin; Lincomycin; Mitomycins; Novobiocin; Olivomycins; Oxytetracycline; Polysaccharides, Bacterial; Rifampin; Serratia marcescens; Spectrum Analysis; Streptomycin; Streptovaricin; Tetracycline; Ultraviolet Rays | 1968 |
Genitourinary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide; Female; Follow-Up Studies; Humans; Hypertension, Renal; Isoniazid; Kanamycin; Male; Nephrectomy; Pyridoxine; Radiography; Rifampin; Tuberculosis, Renal; Tuberculosis, Urogenital; United States | 1974 |
[Current status of chemotherapy of pulmonary tuberculosis and its further prospectives].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Hemorrhagic Disorders; Humans; Isoniazid; Kanamycin; Phenylthiourea; Purpura, Thrombocytopenic; Pyrazines; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Antibiotic-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Erythromycin; Fusidic Acid; Gentamicins; History, 20th Century; Kanamycin; Lactams; Neomycin; Novobiocin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcus aureus; Tetracycline | 1981 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Gastrectomy; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections; Respiratory Tract Infections; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
4 trial(s) available for kanamycin a and rifampin
| Article | Year |
|---|---|
Drug-induced heart failure in advanced pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Heart Failure; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Ethambutol; Female; Fluoroquinolones; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Survival Analysis; Treatment Outcome | 1999 |
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
257 other study(ies) available for kanamycin a and rifampin
| Article | Year |
|---|---|
Synthesis and antibacterial activity of 2,2'-dithiobis(benzamide) derivatives against Mycobacterium species.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Mice; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Structure-Activity Relationship; Sulfides | 1985 |
Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity.
Topics: Antitubercular Agents; Chromatography, Liquid; Diterpenes; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Turkey | 1997 |
Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.
Topics: Anti-Bacterial Agents; Escherichia coli; Glycosylation; Photochemotherapy; Porphyrins; Staphylococcus aureus | 1998 |
Antituberculous activity of some aryl semicarbazone derivatives.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship | 2004 |
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Integerrimides A and B, cyclic heptapeptides from the latex of Jatropha integerrima.
Topics: Animals; Antineoplastic Agents, Phytogenic; Candida albicans; Chickens; Drug Screening Assays, Antitumor; Herpesvirus 1, Human; Humans; Jatropha; Latex; Molecular Structure; Neurites; Peptides, Cyclic; Plants, Medicinal; Plasmodium falciparum; Spinal Cord; Thailand | 2006 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.
Topics: Antifungal Agents; Antimalarials; Antitubercular Agents; Benzoquinones; Biotransformation; Candida albicans; Cordia; Drug Resistance, Multiple; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Terpenes; Thailand | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Topics: Alkanes; Animals; Antitubercular Agents; Cattle; Cell Line; Cell Survival; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Prenylation | 2009 |
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Carbohydrates; Chemistry, Pharmaceutical; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfides | 2009 |
Norselic acids A-E, highly oxidized anti-infective steroids that deter mesograzer predation, from the Antarctic sponge Crella sp.
Topics: Animals; Antarctic Regions; Anti-Infective Agents; Candida albicans; Enterococcus faecium; Leishmania; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Porifera; Staphylococcal Infections; Steroids; Vancomycin Resistance | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
Topics: Antitubercular Agents; Curcuma; Curcumin; Humans; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
Topics: Amino Acid Sequence; Bacterial Proteins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Ethidium; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Onium Compounds; Organophosphorus Compounds; Phylogeny; Sequence Homology, Amino Acid; Sodium Dodecyl Sulfate; Staphylococcus aureus; Trimethoprim; Vancomycin | 2010 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivatives.
Topics: Aminoquinolines; Antiprotozoal Agents; Antitubercular Agents; Biological Assay; Blood-Brain Barrier; Computer Simulation; Drug Design; Erythrocytes; Humans; Inhibitory Concentration 50; Mefloquine; Microbial Sensitivity Tests; Models, Biological; Mycobacterium tuberculosis; Plasmodium falciparum; Quinine; Structure-Activity Relationship; Tetrazoles | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Chlorinated coumarins from the polypore mushroom Fomitopsis officinalis and their activity against Mycobacterium tuberculosis.
Topics: Agaricales; Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Cytotoxins; Hydrocarbons, Chlorinated; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Vero Cells | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
Topics: Acetyl-CoA Carboxylase; Anti-Bacterial Agents; Carboxyl and Carbamoyl Transferases; Enzyme Inhibitors; Microbial Sensitivity Tests; Oxazoles | 2014 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |
Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Binding Sites; Drug Evaluation, Preclinical; Enzyme Inhibitors; Kinetics; Light; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxidation-Reduction; Protein Structure, Tertiary; Rose Bengal; SEC Translocation Channels; SecA Proteins; Staphylococcus aureus | 2015 |
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
Topics: Animals; Antitubercular Agents; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Drug Design; Half-Life; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Pyrazoles; Pyrimidines; Rats; Solubility; Structure-Activity Relationship | 2015 |
One-pot synthesis and antimicrobial evaluation of novel 3-cyanopyridine derivatives of (-)-β-pinene.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bicyclic Monoterpenes; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Monoterpenes; Pyridines; Stereoisomerism; Structure-Activity Relationship | 2016 |
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis | 2016 |
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Combinatorial Chemistry Techniques; Green Chemistry Technology; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidines; Tuberculosis | 2016 |
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
Novel tetrazoloquinoline-rhodanine conjugates: Highly efficient synthesis and biological evaluation.
Topics: Quinolines; Rhodanine | 2016 |
GroEL/ES inhibitors as potential antibiotics.
Topics: Anti-Bacterial Agents; Cell Line; Chaperonin 10; Chaperonin 60; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Computational Biology; Dose-Response Relationship, Drug; Fungi; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Humans; Mycobacterium tuberculosis; Oxadiazoles | 2016 |
Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Line; Humans; Metalloproteases; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium Infections; Mycobacterium tuberculosis; Quinolines; Rhodanine | 2017 |
New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Hydrazones; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium; Mycobacterium bovis; Structure-Activity Relationship; Thiazoles | 2017 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
Topics: Antitubercular Agents; Cell Line, Tumor; Curcumin; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Quinolines | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.
Topics: Administration, Oral; Animals; Antitubercular Agents; Blood Proteins; Drug Stability; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Mycobacterium tuberculosis; Proteomics; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life.
Topics: Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Microbial Sensitivity Tests; Molecular Structure; Particle Size; Peptidomimetics; Structure-Activity Relationship; Tuberculosis | 2018 |
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Erythromycin; Heterocyclic Compounds, 2-Ring; Imidazoles; Imipenem; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Ofloxacin; Protein Serine-Threonine Kinases; Rifampin | 2019 |
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
Topics: Anti-Bacterial Agents; Antifungal Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Gram-Positive Bacteria; Humans; Molecular Structure; Quinolones; Spectrum Analysis; Streptomyces | 2019 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
Topics: Animals; Anti-Bacterial Agents; Hydrazines; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship | 2022 |
Novel β-Hairpin Antimicrobial Peptides Containing the β-Turn Sequence of -RRRF- Having High Cell Selectivity and Low Incidence of Drug Resistance.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Peptides; Drug Resistance, Multiple, Bacterial; Incidence; Mice; Microbial Sensitivity Tests; Peptides | 2022 |
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.
Topics: Animals; Antitubercular Agents; Long QT Syndrome; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
Topics: | 2022 |
Synthesis, biological evaluation and computational studies of pyrazole derivatives as
Topics: | 2022 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
Topics: Capreomycin; Culture Media; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin; Temperature; Thiosemicarbazones; Viomycin | 1975 |
High-pressure liquid chromatography of antibiotics.
Topics: Anti-Bacterial Agents; Bacitracin; Chromatography; Clindamycin; Dactinomycin; Daunorubicin; Erythromycin; Griseofulvin; Hydrocarbons; Kanamycin; Novobiocin; Oxytetracycline; Penicillins; Polymers; Pressure; Rifampin; Tetracycline; Virginiamycin | 1975 |
Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
Topics: Capreomycin; Cross Reactions; Drug Resistance, Microbial; In Vitro Techniques; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Viomycin | 1977 |
Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
Topics: Aminosalicylic Acid; Ethiopia; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thiosemicarbazones | 1978 |
[A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Enviomycin; Ethionamide; Humans; Kanamycin; Mycobacterium tuberculosis; Paromomycin; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1978 |
[The use of mycobacteria in the estimation of the concentration of antibiotics, antimycotics and antituberculotics (author's transl)].
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacitracin; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Time Factors | 1978 |
[Ultrastructural change in Mycobacterium tuberculosis under the influence of antibacterial preparations (a review of the literature)].
Topics: Antitubercular Agents; Cell Nucleus; Cell Wall; Cycloserine; Cytoplasm; Ethambutol; Intracellular Membranes; Isoniazid; Kanamycin; Microscopy, Electron; Microscopy, Electron, Scanning; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1979 |
[Survey of the sensitivity of the strains Neisseria gonorrhoeae to antibioticas in the CSSR during 1957-1973 (authors transl)].
Topics: Ampicillin; Cephaloridine; Cephalothin; Czechoslovakia; Doxycycline; Erythromycin; Female; Humans; Kanamycin; Male; Neisseria gonorrhoeae; Penicillin G; Penicillin Resistance; Retrospective Studies; Rifampin; Spectinomycin; Streptomycin; Tetracycline | 1975 |
[Combination of novoimanine with antibiotics with a different mechanism of action].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cell Division; Drug Interactions; Drug Synergism; Fusidic Acid; Histones; Kanamycin; Plant Extracts; Plants, Medicinal; Rifampin; Spectinomycin; Staphylococcus aureus | 1975 |
Antimicrobial resistance and R factors in Salmonella isolated from humans and animals in Georgia and South Carolina.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Gentamicins; Georgia; Humans; Kanamycin; Microbial Sensitivity Tests; Nitrofurantoin; Penicillin Resistance; R Factors; Rifampin; Salmonella; Serotyping; South Carolina; Spectinomycin; Streptomycin; Sulfamethoxazole; Tetracycline; Tobramycin; Trimethoprim | 1977 |
[Isolation of Actinomadura from soils on selective media with kanamycin and rifampicin].
Topics: Bacteriological Techniques; Culture Media; Kanamycin; Kazakhstan; Microbial Sensitivity Tests; Nocardia; Rifampin; Soil Microbiology; Streptomyces | 1978 |
Analysis of metabolic changes in revertants of antibiotic-resistant micobacteria.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Extrachromosomal Inheritance; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Viomycin | 1975 |
[Antibiotic resistance transmissible in "minor" Salmonella strains recently isolated in the Piedmont region].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Gentamicins; Humans; Italy; Kanamycin; Nalidixic Acid; R Factors; Rifampin; Salmonella; Streptomycin; Tetracycline | 1979 |
[Mode of action of antituberculosis drugs on tubercle bacilli--electron microscopic study and biosynthetic study (author's transl)].
Topics: Antitubercular Agents; Kanamycin; Mycobacterium; Rifampin | 1977 |
In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Chloramphenicol; Cross Infection; Erythromycin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Rifampin; Serratia marcescens; Sputum; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Urine; Wound Infection | 1976 |
[Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefazolin; Cephaloridine; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Injections, Intramuscular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Nitroquinolines; Pyelonephritis; Rats; Rifampin; Sulfamethoxypyridazine; Urine | 1976 |
Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Drug Antagonism; Kanamycin; Penicillin Resistance; Rifampin; Streptococcus | 1976 |
Hemophilus influenzae type B susceptibility to 17 antibiotics.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephaloridine; Cephalothin; Cephradine; Chloramphenicol; Clindamycin; Culture Media; Erythromycin; Gentamicins; Haemophilus influenzae; Kanamycin; Penicillin G; Penicillin Resistance; Rifampin; Tetracycline | 1975 |
[Action mechanism of anti-tuberculosis drugs].
Topics: Kanamycin; Mycobacterium bovis; Rifampin; RNA, Bacterial | 1975 |
Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case.
Topics: Adolescent; Bone Diseases; Bone Neoplasms; Child; Diagnosis, Differential; Ethambutol; Hodgkin Disease; Humans; Isoniazid; Kanamycin; Male; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Radiography; Rifampin; Time Factors | 1975 |
Ethanol-antibiotic interactions at hepatic level.
Topics: Acute Disease; Alcoholic Intoxication; Animals; Anti-Bacterial Agents; Chronic Disease; Drug Interactions; Ethanol; Gentamicins; Humans; Isoniazid; Kanamycin; Liver; Male; Rats; Rifampin; Streptomycin; Sulfobromophthalein | 1975 |
Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.
Topics: Catalase; Chromatography, Thin Layer; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; In Vitro Techniques; Isoniazid; Kanamycin; Mutagenesis; Mycobacterium; Mycolic Acids; Peroxidases; Rifampin; Streptomycin | 1992 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
[In vitro experiment showing that chemotherapy of tuberculosis by aminoglycoside antibiotics may influence successive chemotherapy with rifampicin].
Topics: Anti-Bacterial Agents; Drug Interactions; Drug Resistance, Microbial; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis | 1991 |
The activity of amoxicillin plus clavulanic acid against Mycobacterium leprae in mice.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Dapsone; Drug Therapy, Combination; Kanamycin; Kinetics; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1991 |
MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Culture Media; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1988 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Pyrazinamide; Rifampin | 1989 |
Differentiation between genera Rhodococcus and Nocardia by susceptibility testing to kanamycin and some other antituberculosis agents.
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Kanamycin; Kanamycin Resistance; Minocycline; Nocardia; Nocardia asteroides; Rhodococcus; Rifampin; Streptomycin | 1988 |
Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
Topics: Animals; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Humans; Kanamycin; Mycobacterium; Mycobacterium avium; Mycobacterium leprae; Mycobacterium lepraemurium; Nontuberculous Mycobacteria; R Factors; Rifampin; Streptomycin | 1986 |
Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
Topics: Animals; Drug Therapy, Combination; Kanamycin; Leprosy; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Streptomycin; Time Factors | 1987 |
Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Amikacin; Animals; Child; Drug Therapy, Combination; Humans; Kanamycin; Kinetics; Meningitis; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1985 |
[Sensitivity of Proteus mirabilis to drugs in the presence of human blood serum].
Topics: Anti-Bacterial Agents; Blood; Blood Bactericidal Activity; Cephaloridine; Chloramphenicol; Culture Media; Gentamicins; Humans; In Vitro Techniques; Kanamycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Proteus mirabilis; Rifampin | 1985 |
In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Colistin; Dihydrostreptomycin Sulfate; Drug Synergism; Erythromycin; Flavobacterium; Folic Acid Antagonists; Gentamicins; Kanamycin; Lincomycin; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Penicillins; Pyrimidines; Rifampin; Sulfamethoxazole; Tetracycline; Vancomycin | 1971 |
Clinical results of rifampicin treatment.
Topics: Administration, Oral; Adult; Aged; Capreomycin; Chronic Disease; Drug Combinations; Ethambutol; Female; Humans; Kanamycin; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Oxytetracycline; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1970 |
Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chloramphenicol; Chlortetracycline; Dihydrostreptomycin Sulfate; Drug Stability; Erythromycin; Gastric Juice; Hydrogen-Ion Concentration; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Novobiocin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rifampin; Solutions; Staphylococcal Infections; Staphylococcus; Streptococcal Infections | 1972 |
[Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1971 |
Permeability of tuberculous cavities to antituberculosis drugs.
Topics: Adult; Antitubercular Agents; Capreomycin; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Lung; Middle Aged; Mycobacterium tuberculosis; Permeability; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1972 |
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
Topics: Adolescent; Adult; Africa, Northern; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Ethnicity; Female; France; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary; Viomycin | 1972 |
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Thrombocytopenia; Viomycin | 1973 |
Nontuberculous mycobacterial infections of man.
Topics: Capreomycin; Child; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Lung Diseases; Lymphadenitis; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Sputum; Streptomycin | 1974 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Treatment of pulmonary tuberculosis.
Topics: Capreomycin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cycloserine; Depression; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Kanamycin; Kidney Diseases; Optic Neuritis; Patient Education as Topic; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Drug Synergism; Erythromycin; Folic Acid Antagonists; Gentamicins; Kanamycin; Lincomycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Pyrimidines; Rifampin; Streptomycin; Sulfamethoxazole; Tetracycline | 1970 |
The effect of radiation on microbiologic characteristics of M tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cell Survival; Chromosomes, Bacterial; Cycloserine; Dose-Response Relationship, Radiation; Drug Resistance, Microbial; Ethambutol; Ethionamide; Freezing; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Preservation, Biological; Pyrazinamide; Radiation Genetics; Rifampin; Streptomycin | 1974 |
In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bacteriological Techniques; Chick Embryo; Chloramphenicol; Culture Techniques; Dimethyl Sulfoxide; Doxycycline; Erythromycin; Gentamicins; Kanamycin; Minocycline; Neomycin; Oxacillin; Penicillin G; Rickettsia Infections; Rickettsia prowazekii; Rifampin; Streptomycin; Tetracycline; Ultrafiltration; Vancomycin | 1974 |
[Effect of rifampicin on the intra- and extracellularly located Mycobacterium tuberculosis].
Topics: Animals; Cells, Cultured; Drug Resistance, Microbial; Kanamycin; Mice; Mycobacterium tuberculosis; Phagocytosis; Pyrazinamide; Rifampin; Spleen; Streptomycin | 1974 |
[Bactericidal power of antibiotic combinations of rifamycin S.V. on pathogenic staphylococci].
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Drug Antagonism; Drug Synergism; Erythromycin; Gentamicins; Kanamycin; Lincomycin; Novobiocin; Penicillins; Rifampin; Staphylococcus; Tetracycline | 1970 |
Chromosomal location of antibiotic resistance markers in Bacillus subtilis.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Chromosome Mapping; Chromosomes, Bacterial; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Microbial; Kanamycin; Lincomycin; Molecular Biology; Mutation; Neomycin; Novobiocin; Recombination, Genetic; Rifampin; RNA Nucleotidyltransferases; RNA, Bacterial; Spectinomycin; Spores; Transduction, Genetic; Transformation, Genetic | 1970 |
[Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Thiosemicarbazones; Viomycin | 1966 |
The susceptibility of mycobacteria to rifamide and rifampicin.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1967 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1968 |
[Rifampicin: a bacteriostatic and bactericidal agent].
Topics: Ampicillin; Bacteria; Bacteriological Techniques; Cephalosporins; Colistin; Drug Antagonism; Drug Synergism; Escherichia coli; Kanamycin; Nalidixic Acid; Penicillin G; Penicillin Resistance; Polymyxins; Pseudomonas aeruginosa; Rifampin; Serratia marcescens; Staphylococcus; Sulfonamides; Tetracycline | 1969 |
[Drug sensitivity of the so-called atypical mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Morpholines; Mycobacterium; Pyrazinamide; Pyrazines; Rifampin; Streptomycin; Viomycin | 1968 |
Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalosporins; Cephalothin; Chloramphenicol; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Nalidixic Acid; Neomycin; Novobiocin; Penicillin G; Penicillin Resistance; Polymyxins; Rifampin; Streptomycin; Tetracycline | 1970 |
[Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Kanamycin; Mycobacterium tuberculosis; Piperazines; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1970 |
[Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitubercular Agents; Body Weight; Ethambutol; Ethionamide; Injections, Intramuscular; Kanamycin; Lung; Mice; Organ Size; Pyrazinamide; Rifampin; Spleen; Tuberculosis; Viomycin | 1971 |
[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
[Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Chloramphenicol; Colistin; Exudates and Transudates; Gentamicins; Humans; Kanamycin; Lincomycin; Microbial Sensitivity Tests; Polymyxins; Pseudomonas aeruginosa; Rifampin; Sputum; Streptomycin; Tetracycline | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Hypothyroidism; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Experimental study of the most rational combinations of rifocin with different antibiotics in relation to inducers of surgical infection].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteriuria; Carbenicillin; Chloramphenicol; Depression, Chemical; Drug Antagonism; Drug Synergism; Erythromycin; Escherichia coli; Exudates and Transudates; Humans; Kanamycin; Methacycline; Novobiocin; Oxytetracycline; Proteus; Pseudomonas aeruginosa; Rifampin; Ristocetin; Sepsis; Sputum; Staphylococcus; Surgical Wound Infection | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
Topics: Antitubercular Agents; Bacteriological Techniques; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Viomycin | 1971 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
The susceptibility of Bacteroides fragilis to 24 antibiotics.
Topics: Anti-Bacterial Agents; Bacteroides; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Erythromycin; Gentamicins; Humans; Kanamycin; Lincomycin; Microbial Sensitivity Tests; Penicillin Resistance; Polymyxins; Rifampin; Streptomycin; Tetracycline | 1972 |
[Tuberculostatics. General adverse effects].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Neomycin; Oxytetracycline; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1972 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
Outbreak of a nosocomial infection with a strain of Proteus rettgeri resistant to many antimicrobials.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cephalothin; Chicago; Chloramphenicol; Cross Infection; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Penicillin Resistance; Polymyxins; Proteus; Proteus Infections; Rifampin; Species Specificity; Tetracycline | 1974 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
Topics: Adult; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Evaluation; Ethambutol; Ethionamide; Female; Hospitals, Special; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary; Viomycin | 1974 |
[Tubulointerstitial nephropathies due to antibiotics].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cephalexin; Cephaloridine; Cephalothin; Drug Hypersensitivity; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kidney Tubules; Nephritis; Nephritis, Interstitial; Penicillins; Polyenes; Polymyxins; Rifampin | 1973 |
[Occurrence of cultures with episomal resistance to antibiotics among shigellae isolated in Kiev].
Topics: Ampicillin; Chloramphenicol; Clioquinol; Erythromycin Ethylsuccinate; Escherichia coli; Furazolidone; Humans; Kanamycin; Nalidixic Acid; Neomycin; Nitro Compounds; Nitrofurans; Nitrofurazone; Oxyquinoline; Penicillin Resistance; Plasmids; Polymyxins; Recombination, Genetic; Rifampin; Shigella flexneri; Shigella sonnei; Streptomycin; Tetracycline; Ukraine | 1974 |
Antibiotic sensitivity of staphylococci isolated in Ulanbator. On the occasion of the 50th anniversary of the Mongolian health services.
Topics: Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Kanamycin; Leucomycins; Lincomycin; Microbial Sensitivity Tests; Mongolia; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1972 |
Further characterization of suckling mouse cataract agent (SMCA): a slow, persistent infection of the nervous system.
Topics: Animals; Arboviruses; Bromodeoxyuridine; Cataract; Chick Embryo; Dactinomycin; Filtration; Hot Temperature; Hydrogen-Ion Concentration; Hydroxyurea; Inclusion Bodies, Viral; Kanamycin; Lens, Crystalline; Mice; Micropore Filters; Microscopy, Electron; Nervous System Diseases; Organ Culture Techniques; Particle Size; Penicillin Resistance; Penicillins; Rabbits; Rifampin; Slow Virus Diseases; Streptomycin; Trypsin; Ultraviolet Rays; Virus Replication | 1972 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
Geographical differences in antibiotic sensitivity patterns: comparison of susceptibility of staphylococci in Poland and Germany.
Topics: Cephaloridine; Chloramphenicol; Erythromycin; Framycetin; Fusidic Acid; Geography; Germany, West; Kanamycin; Lincomycin; Nitrofurantoin; Penicillin Resistance; Penicillins; Poland; Rifampin; Species Specificity; Staphylococcus; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1973 |
Progress towards agreement in reports of antibiotic sensitivity.
Topics: Cephalosporins; Chloramphenicol; Cloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Lincomycin; Methicillin; Microbial Sensitivity Tests; Neomycin; Novobiocin; Penicillin Resistance; Penicillinase; Penicillins; Rifampin; Staphylococcus; Streptomycin; Sulfonamides; Tetracycline | 1974 |
Application of experimental keratoconjunctivitis shigellosa in chemotherapeutic evaluation of rifampicin to bacillary dysentery.
Topics: Animals; Cornea; Disease Models, Animal; Dysentery, Bacillary; Epithelial Cells; Escherichia coli; Evaluation Studies as Topic; Guinea Pigs; Injections, Intramuscular; Kanamycin; Keratoconjunctivitis; Ophthalmic Solutions; Rifampin; Shigella; Shigella flexneri; Streptomycin; Tetracycline | 1972 |
Application of cell culture in studying antibacterial activity of rifampicin to Shigella and enteropathogenic Escherichia coli.
Topics: Animals; Cells, Cultured; Chloramphenicol; Escherichia coli; Escherichia coli Infections; HeLa Cells; Kanamycin; L Cells; Male; Mice; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Rifampin; Shigella; Shigella flexneri; Streptomycin; Tetracycline | 1972 |
Inhibition of cell to cell transfer of Shigella by treatment with some antibiotics.
Topics: Anti-Bacterial Agents; Colistin; Erythromycin; HeLa Cells; Kanamycin; Rifampin; Shigella; Shigella flexneri; Tetracycline | 1973 |
Simultaneous transfer of gentamicin and kanamycin resistance from a urine strain of Escherichia coli.
Topics: Bacteriuria; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Kanamycin; Nalidixic Acid; Rifampin; Species Specificity; Streptomycin | 1973 |
Chemotherapy and antibiotic-resistance transfer between Enterobacteria in the human gastro-intestinal tract.
Topics: Age Factors; Ampicillin; Chloramphenicol; Chromosomes, Bacterial; Escherichia coli; Extrachromosomal Inheritance; Feces; Genetics, Microbial; Humans; Intestines; Kanamycin; Male; Microbial Sensitivity Tests; Nalidixic Acid; Penicillin Resistance; Rifampin; Streptomycin; Tetracycline | 1973 |
Studies on the nature of plasmids arising from conjugation in the human gastro-intestinal tract.
Topics: Ampicillin; Antigens, Bacterial; Carbon Isotopes; Chloramphenicol; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Extrachromosomal Inheritance; Genetics, Microbial; Humans; Intestines; Kanamycin; Nalidixic Acid; Nucleic Acid Hybridization; Penicillin Resistance; Rifampin; Serotyping; Streptomycin; Sulfonamides; Tetracycline; Tritium | 1973 |
The effect of R-factor carriage on the survival of Escherichia coli in the human intestine.
Topics: Ampicillin; Chloramphenicol; Escherichia coli; Extrachromosomal Inheritance; Feces; Humans; Intestines; Kanamycin; Microbial Sensitivity Tests; Nalidixic Acid; Penicillin Resistance; Rifampin; Streptomycin; Sulfonamides; Tetracycline | 1974 |
Host cell changes induced by R factors and other sex factors.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cell Membrane; Chloramphenicol; Chromosomes, Bacterial; Conjugation, Genetic; DNA, Bacterial; DNA, Circular; Escherichia coli; Extrachromosomal Inheritance; Glycolipids; Kanamycin; Microbial Sensitivity Tests; Organophosphorus Compounds; Penicillin Resistance; Phenotype; Rifampin; Salmonella typhimurium; Sex; Streptomycin; Sulfonamides; Tetracycline | 1973 |
Chemotherapeutic evaluation of rifampicin to experimental bacillary dysentery in cynomolgus monkeys.
Topics: Animals; Cecum; Colon; Dysentery, Bacillary; Evaluation Studies as Topic; Feces; Fluorescent Antibody Technique; Haplorhini; Ileocecal Valve; Ileum; Intestinal Mucosa; Kanamycin; Macaca; Rectum; Rifampin; Shigella flexneri | 1972 |
[Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
Topics: Adolescent; Adult; Aged; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pneumonectomy; Postoperative Complications; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Transfer of gentamicin resistance from Pseudomonas aeruginosa strains highly resistant to gentamicin and carbenicillin.
Topics: Carbenicillin; Culture Media; Escherichia coli; Genetics, Microbial; Gentamicins; Kanamycin; Mutation; Penicillin Resistance; Pseudomonas aeruginosa; Rifampin | 1973 |
[Current status of the medical treatment of Hansen's disease].
Topics: Glucocorticoids; Humans; Kanamycin; Leprosy; Rifampin; Sulfonamides; Sulfones; Thalidomide; Thiourea | 1972 |
Treatment of venereal diseases.
Topics: Chancroid; Drug Combinations; Erythromycin; Female; Gonorrhea; Granuloma Inguinale; Humans; Injections, Intramuscular; Kanamycin; Lymphogranuloma Venereum; Male; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Sexually Transmitted Diseases; Streptomycin; Sulfamethoxazole; Sulfonamides; Syphilis; Tetracycline; Trimethoprim; Urethritis | 1973 |
[Chronic tuberculous meningitis in a case of known Mycobacterium kansasii infection].
Topics: Adult; Burns; Cell Count; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Lymphocytes; Male; Mycobacterium; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Uveitis | 1974 |
Use of a new rifamycin SV derivative in chronic urinary infections.
Topics: Adolescent; Adult; Aged; Bacteriuria; Cephalothin; Chloramphenicol; Chronic Disease; Colistin; Drug Resistance, Microbial; Escherichia coli Infections; Female; Gentamicins; Humans; Kanamycin; Male; Methacycline; Middle Aged; Oxytetracycline; Proteus Infections; Rifampin; Sulfamethoxypyridazine; Urinary Tract Infections | 1970 |
[Comparative study of the sensitivity to different antibiotics of Staphylococci isolated from patients and attendants].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Cephalothin; Chloramphenicol; Cross Infection; Erythromycin; Erythromycin Ethylsuccinate; Humans; Kanamycin; Lincomycin; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Personnel, Hospital; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Tetracycline | 1971 |
Rifampin-blood-agar as a selective medium for the isolation of certain anaerobic bacteria.
Topics: Agar; Anaerobiosis; Anti-Infective Agents, Local; Bacteriological Techniques; Bacteroides; Blood; Clostridium; Coloring Agents; Culture Media; Eubacterium; Feces; Fusobacterium; Humans; Kanamycin; Neomycin; Rifampin; Species Specificity | 1971 |
The interaction patterns of combined antibacterial agents. Experiments with two agardiffusion methods.
Topics: Ampicillin; Chloramphenicol; Colistin; Drug Antagonism; Drug Synergism; Enterobacteriaceae; Erythromycin; Escherichia coli; Fusidic Acid; Kanamycin; Klebsiella; Methicillin; Nalidixic Acid; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Rifampin; Salmonella; Staphylococcus; Streptococcus; Streptomycin; Tetracycline | 1966 |
[Study on the sensitivity to antibiotics of 164 anaerobic asporulales and 50 anaerobic actinomycetales].
Topics: Ampicillin; Bacteria; Chloramphenicol; Colistin; Demeclocycline; Erythromycin; Kanamycin; Leucomycins; Methicillin; Novobiocin; Oxacillin; Penicillin G; Penicillin V; Rifampin; Streptomycin; Tetracycline | 1966 |
Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Sputum; Tuberculosis, Pulmonary | 1971 |
Mode of action of antituberculous agents and ultrastructure of mycobacteria.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Isoniazid; Kanamycin; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1971 |
[Sensitivity to antibiotics of 65 strains of gonococcus isolated at Algiers in 1969-70].
Topics: Algeria; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Culture Media; Erythromycin; Kanamycin; Leucomycins; Neisseria gonorrhoeae; Penicillin G; Penicillin Resistance; Peptides; Rifampin; Streptomycin; Sulfonamides; Tetracycline | 1970 |
[Efficiency of interrupted therapy of tuberculosis (experimental study)].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Methods; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
Chemotherapy of gonorrhea: a review of current status.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Gonorrhea; Humans; Kanamycin; Penicillins; Probenecid; Rifampin; Sulfonamides; Trimethoprim | 1972 |
[Treatment of tuberculosis resistant to 1st line drugs with rifampycin and ethambutol, twice a week, with an initial supplement of kanamycin].
Topics: Drug Resistance, Microbial; Ethambutol; Female; Humans; Kanamycin; Male; Rifampin; Tuberculosis, Pulmonary | 1971 |
The antistaphylococcal activity of Rifampicin.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Kanamycin; Lincomycin; Novobiocin; Oxacillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus; Time Factors | 1969 |
Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides; Clostridium; Colistin; Culture Media; Erythromycin; Fusobacterium; Kanamycin; Microbial Sensitivity Tests; Neomycin; Penicillin Resistance; Penicillins; Peptostreptococcus; Rifampin | 1971 |
Experimental animal investigations with rifampicin on the question of its influence on the vestibular system and its period of retention in the perilymph of the inner ear.
Topics: Administration, Oral; Animals; Guinea Pigs; Kanamycin; Lymph; Nystagmus, Pathologic; Penicillins; Rabbits; Rifampin; Streptomycin; Tetracycline; Time Factors; Vestibular Function Tests; Vestibule, Labyrinth | 1970 |
[Sensitivity of staphylococci to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Chlortetracycline; Culture Media; Erythromycin; Kanamycin; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcus; Streptomycin; Vancomycin; Virginiamycin | 1966 |
Renal effects of antituberculous antibiotics.
Topics: Administration, Oral; Alkaline Phosphatase; Animals; Antitubercular Agents; Body Weight; Ethambutol; Female; Injections, Intraperitoneal; Kanamycin; Kidney; L-Lactate Dehydrogenase; Leucyl Aminopeptidase; Male; Rats; Rifampin; Streptomycin | 1970 |
[Colloquium on class II antitubercular agents].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin | 1969 |
Long-term antibiotic susceptibility pattern of strains of Neisseria gonorrhoeae isolated in Czechoslovakia in the years 1957-1982.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Czechoslovakia; Doxycycline; Erythromycin; Kanamycin; Neisseria gonorrhoeae; Penicillin G; Rifampin; Spectinomycin; Tetracycline; Time Factors | 1982 |
Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice.
Topics: Animals; Antitubercular Agents; Chronic Disease; Cycloserine; Disease Models, Animal; Drug Therapy, Combination; Ethambutol; Kanamycin; Liver; Lung; Male; Mice; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Spleen; Time Factors | 1984 |
[Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Italy; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
[A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)].
Topics: Drug Resistance, Microbial; Ethambutol; Kanamycin; Mycobacterium tuberculosis; Prothionamide; Rifampin | 1981 |
Adverse effects of antituberculosis drugs causing changes in treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
An antibiotic dependent conditional lethal mutant with a lesion affecting transcription and translation.
Topics: DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Escherichia coli; Genes, Lethal; Kanamycin; Mutation; Phenotype; Protein Biosynthesis; Rifampin; Transcription, Genetic | 1981 |
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Rifampin; Streptomycin | 1982 |
Defective transformation of chromosomal markers in DNA polymerase I mutants of the radioresistant bacterium Deinococcus radiodurans.
Topics: Acriflavine; Chloramphenicol; DNA Damage; DNA Polymerase I; Gamma Rays; Genes, Bacterial; Genetic Markers; Genotype; Gram-Positive Cocci; Kanamycin; Models, Genetic; Mutagenesis, Insertional; Mutagenesis, Site-Directed; Mutation; Plasmids; Rifampin; Transformation, Bacterial; Ultraviolet Rays | 1994 |
[Effectiveness of regional lymphotropic therapy in combined treatment of tuberculosis in adolescents].
Topics: Adolescent; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Guinea Pigs; Humans; Injections, Intralymphatic; Isoniazid; Kanamycin; Male; Radiography; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Lung; Male; Mice; Mycobacterium avium Complex; Rifampin; Rifamycins; Spleen; Tuberculosis | 1996 |
A resected case of Mycobacterium szulgai pulmonary disease.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP].
Topics: Adenosine Triphosphate; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1998 |
[Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
[Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Monitoring; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium bovis; Mycobacterium kansasii; Mycobacterium tuberculosis; Rifampin; Russia; Streptomycin | 2001 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Drug Administration Schedule; Drug Resistance, Bacterial; Ethambutol; Female; Genetics, Microbial; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2002 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents.
Topics: Ampicillin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Gene Expression; Gene Expression Profiling; Kanamycin; Microbial Sensitivity Tests; Norfloxacin; Oligonucleotide Array Sequence Analysis; Rifampin; Transcription, Genetic | 2003 |
[M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Incidence; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Ukraine | 2003 |
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Topics: Adolescent; Anti-Bacterial Agents; Genotype; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Bactericidal therapy in patients with tuberculosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Chlortetracycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2004 |
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ozone; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Two cases of Mycobacterium szulgai pulmonary disease in the elderly].
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Male; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 2005 |
System for determining the relative fitness of multiple bacterial populations without using selective markers.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Biomarkers; Culture Media; Drug Resistance, Bacterial; Escherichia coli; Kanamycin; Pseudomonas putida; Rifampin; Serratia marcescens | 2006 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2008 |
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Topics: Antitubercular Agents; Bacteriological Techniques; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Isoniazid; Kanamycin; Male; Microscopy, Fluorescence; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2009 |
Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates.
Topics: Agar; Anti-Bacterial Agents; Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity | 2009 |
Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Drug Design; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fibroblasts; HeLa Cells; Humans; Kanamycin; Mice; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Rifampin | 2010 |
Enhancement of antimicrobial activity by synthetic ion channel synergy.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Erythromycin; Escherichia coli; Ion Channels; Kanamycin; Microbial Sensitivity Tests; Rifampin; Tetracycline | 2010 |
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Female; Kanamycin; Luminescence; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin | 2011 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; South Africa; Streptomycin | 2011 |
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin | 2011 |
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Topics: Antitubercular Agents; Bacteriophages; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Promoter Regions, Genetic; Recombinant Proteins; Rifampin; Signal-To-Noise Ratio; Sputum; Tuberculosis, Pulmonary | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Biological Transport; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Ethambutol; Genotype; Isoniazid; Kanamycin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Protein Structure, Secondary; Protein Structure, Tertiary; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Contribution of phenotypic heterogeneity to adaptive antibiotic resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Separation; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Flow Cytometry; Gene Expression Regulation, Bacterial; Green Fluorescent Proteins; Kanamycin; Microscopy, Fluorescence; Mutation; Nalidixic Acid; Phenotype; Porins; Rifampin; Salmonella enterica | 2014 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; Genotype; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China.
Topics: Antitubercular Agents; Bacteriological Techniques; China; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Humans; Kanamycin; Microbial Sensitivity Tests; Microscopy; Mutation; Mycobacterium tuberculosis; Ofloxacin; Patient Selection; Predictive Value of Tests; Rifampin; Time Factors | 2014 |
Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genes, MDR; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Republic of Korea; Rifampin; Sputum; Streptomycin | 2015 |
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum | 2015 |
Novel green synthesis of gold nanoparticles using Citrullus lanatus rind and investigation of proteasome inhibitory activity, antibacterial, and antioxidant potential.
Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; Citrullus; Drug Synergism; Free Radical Scavengers; Gold; Green Chemistry Technology; Kanamycin; Metal Nanoparticles; Microbial Sensitivity Tests; Particle Size; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Reference Standards; Rifampin; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; X-Ray Diffraction | 2015 |
Drug-resistant tuberculosis plagues India.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.
Topics: Antitubercular Agents; Ciprofloxacin; Flow Cytometry; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2016 |
Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Topics: Adult; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum | 2016 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
Topics: Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moldova; Mutation; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
Hydraphiles enhance antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Erythromycin; Escherichia coli; Escherichia coli Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Permeability; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Surface-Active Agents; Tetracycline | 2016 |
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Topics: Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genes, Bacterial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Molecular Typing; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2016 |
Surveillance for tuberculosis in a rural community in The Philippines.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Male; Middle Aged; Philippines; Population Surveillance; Prevalence; Prospective Studies; Public Health; Rifampin; Rural Population; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Determination of antimicrobial resistance of Enterococcus strains isolated from pigs and their genotypic characterization by method of amplification of DNA fragments surrounding rare restriction sites (ADSRRS fingerprinting).
Topics: Animals; Anti-Bacterial Agents; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Enterococcus hirae; Erythromycin; Genotyping Techniques; Kanamycin; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Rifampin; Streptomycin; Swine; Tetracycline; Tetracycline Resistance; Tylosin | 2017 |
Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Seoul; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2017 |
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Topics: Antitubercular Agents; Bacterial Typing Techniques; Cohort Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genome, Bacterial; Genotype; Humans; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2018 |
Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Topics: Antitubercular Agents; DNA, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Kanamycin; Laboratories; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Referral and Consultation; Rifampin; South Africa | 2017 |
Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Desiccation; Drug Combinations; Drug Compounding; Dry Powder Inhalers; Humans; Hydrophobic and Hydrophilic Interactions; Kanamycin; Particle Size; Powders; Respiratory Tract Infections; Rifampin; Surface Properties; Wettability | 2018 |
Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug.
Topics: Aerosols; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Dry Powder Inhalers; Hydrophobic and Hydrophilic Interactions; Kanamycin; Particle Size; Powders; Rifampin; Surface Properties | 2018 |
Pyrosequencing: a rapid and effective sequencing method to diagnose drug-resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2018 |
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gene Frequency; Genotype; Humans; Isoniazid; Kanamycin; Kenya; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Linezolid; Lung; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tissue Distribution; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
Topics: Administration, Inhalation; Aerosols; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dry Powder Inhalers; Excipients; Humidity; Hydrophobic and Hydrophilic Interactions; Kanamycin; Microscopy, Electron, Scanning; Particle Size; Powders; Rifampin; Surface Properties; Wettability; X-Ray Diffraction | 2019 |
Whole-genome sequencing analysis of multidrug-resistant
Topics: Adult; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Indonesia; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Phenotype; Phylogeny; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2020 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.
Topics: Adolescent; Adult; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Injections; Kanamycin; Male; Middle Aged; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2020 |
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
Topics: Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uzbekistan | 2021 |
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
Topics: Acetyltransferases; Adult; Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Multivariate Analysis; Mutation; Mutation Rate; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Prospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2021 |
Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.
Topics: Colony Count, Microbial; Flow Cytometry; Humans; Immunologic Tests; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2021 |
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node | 2022 |
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |